New Biomarkers Evaluating Ovarian Cancer

Fujirebio Diagnostics, Inc.280 enrolled

Overview

The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.

Study Type

OBSERVATIONAL

Enrollment

280

Conditions

Adnexal Mass

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Female, age 18 years or older * Adnexal mass present documented by imaging * Scheduled to undergo surgery based on a finding of adnexal mass * Able and willing to provide Informed Consent Exclusion Criteria: * Previous history of ovarian cancer * Previous history of bilateral oophorectomy * Currently known to be pregnant * Unable to provide informed consent

Locations (2)

New Hanover Regional Medical Center

Wilmington, North Carolina, United States

University of Oklahoma

Oklahoma City, Oklahoma, United States

Outcomes

Primary Outcomes

Evaluate novel biomarkers for patients with an adnexal mass

Time frame: observational studies

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.